Summary:
Summit Dermatology is conducting a phase 3 study to test the safety and effectiveness of a topical treatment in patients with moderate to severe acne.
Qualified Participants Must:
• Be 9 years of age or older
•
Have moderate to severe acne
Qualified Participants May Receive:
Study medication, all study visits, diagnostic tests, and $700 for full study participation.